In April, we reported that by the end of 2016, more than 1 million patients will have received Gamma Knife treatment for brain tumors and neurological conditions since the technology’s inception. Last month, Gamma Knife’s manufacturer announced at the 18th International Leksell Gamma Knife Society Meeting in Amsterdam that the milestone has been met, noting that Gamma Knife is the most clinically proven radiosurgery system available, with more than 2,800 peer-reviewed journal articles published to date. CBS 2 also recently reported on Gamma Knife stereotactic radiosurgery’s positive patient outcomes.
“Gamma Knife surgery is a proven technology that enables us to treat more patients with better results than ever before,” says Anthony D’Ambrosio, M.D., Co-Director of The Valley Hospital Gamma Knife Center. “Gamma Knife enables significantly less radiation exposure to healthy tissue than whole brain radiation, reducing potential side effects.”
Gamma Knife works by directing 192 precise beams of radiation that converge at the treatment site, creating a potent dose of concentrated radiation that attacks tumors and abnormalities — while sparing healthy tissue — shrinking them over time or stopping their growth. There are no incisions, anesthesia or hospital stay, and patients can return to normal activities quickly, sometimes within one day.
Could Gamma Knife Help You?
Complete the contact form below to learn more about whether Gamma Knife surgery is right for you.
